(a) For direct measurements performed in accordance with § 35.63, a licensee shall possess and use instrumentation to measure the activity of unsealed byproduct material before it is administered to each patient or human research subject.
(b) A licensee shall calibrate the instrumentation required in paragraph (a) of this section in accordance with nationally recognized standards or the manufacturer's instructions.
(c) A licensee shall retain a record of each instrument calibration required by this section in accordance with § 35.2060.
authority: Atomic Energy Act of 1954, secs. 81, 161, 181, 182, 183, 223, 234, 274 (
42 U.S.C. 2111,
2201,
2231,
2232,
2233,
2273,
2282,
2021; Energy Reorganization Act of 1974, secs. 201, 206 (
42 U.S.C. 5841,
5846;
44 U.S.C. 3504 note
source: 67 FR 20370, Apr. 24, 2002, unless otherwise noted.
cite as: 10 CFR 35.60